Abstract
Hereditary retinal diseases summarize a broad range of genetic disorders with different clinical manifestations. Depending on the genetic mutation, primarily the cones, the rods, or both types of photoreceptors are affected, determining the symptoms and signs of the affected patients.
In this chapter, results of FLIO findings in the most common hereditary retinal diseases including Stargardt disease, choroideremia, and retinitis pigmentosa are summarized.
Characteristic FLIO patterns are observed for every disease. In comparison to commonly used imaging techniques, FLIO provides additional information including evolution of flecks in Stargardt disease, and the integrity of photoreceptor layers in absence of the RPE in choroideremia and retinitis pigmentosa. Regarding early detection or retinal changes in hereditary retinal diseases as well as for diagnostic purposes and follow-up documentation also in the context of upcoming therapeutic interventions, FLIO might provide additional information in comparison to conventional imaging techniques.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Walia S, Fishman GA. Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet. 2009;30(2):63–8.
Haji Abdollahi S, Hirose T. Stargardt-Fundus flavimaculatus: recent advancements and treatment. Semin Ophthalmol. 2013;28(5–6):372–6.
Koenekoop RK. The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet. 2003;24(2):75–80.
Allikmets R, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277(5333):1805–7.
Allikmets R. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;17(1):122.
Smith RT, et al. Lipofuscin and autofluorescence metrics in progressive STGD. Invest Ophthalmol Vis Sci. 2009;50(8):3907–14.
Cukras CA, et al. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol. 2012;130(2):171–9.
Gomes NL, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–9.
Armstrong JD, Xu S, Elfervig JL. Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology. 1998;105:448–57.
Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110(6):1151–8.
Fishman GA, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 1999;117(4):504–10.
Fishman GA, et al. Visual acuity loss in patients with Stargardt's macular dystrophy. Ophthalmology. 1987;94(7):809–14.
Cornelis SS, et al. In Silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum Mutat. 2017;38(4):400–8.
Fishman GA. Fundus flavimaculatus. A clinical classification. Arch Ophthalmol. 1976;94(12):2061–7.
Dysli C, et al. Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression. Invest Ophthalmol Vis Sci. 2016;57(3):832–41.
Dysli C, et al. Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci. 2014;55(4):2106–13.
Dysli C, et al. Fluorescence lifetime imaging ophthalmoscopy. Prog Retin Eye Res. 2017;60:120–43.
Solberg Y, Dysli C, Escher P, Berger L, Wolf S, Zinkernagel MS. Retinal flecks in Stargardt Disease reveal characteristic fluorescence lifetime transition over time. Retina. 2019;39(5):1. https://doi.org/10.1097/IAE.0000000000002519.
Sparrow JR, et al. Flecks in recessive Stargardt disease: short-wavelength autofluorescence, near-infrared autofluorescence, and optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(8):5029–39.
Liu J, et al. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem. 2000;275(38):29354–60.
Dysli C, Wolf S, Zinkernagel MS. Autofluorescence lifetimes in geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57:2479–87. https://doi.org/10.1167/iovs.15-18381.
Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci U S A. 2015;112(27):8415–20.
Campa C, et al. The role of gene therapy in the treatment of retinal diseases: a review. Curr Gene Ther. 2017;17(3):194–213.
Zinkernagel MS, MacLaren RE. Recent advances and future prospects in choroideremia. Clin Ophthalmol. 2015;9:2195–200.
Xue K, et al. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med. 2018;24(10):1507–12.
Dysli C, et al. Autofluorescence lifetimes in patients with choroideremia identify photoreceptors in areas with retinal pigment epithelium atrophy. Invest Ophthalmol Vis Sci. 2016;57(15):6714–21.
Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809.
Shankar S. Hereditary retinal and choroidal dystrophies. In: Rimoin D, Pyeritz R, Korf B, editors. Emery and Rimoin’s principles and practice of medical genetics. London: Academic Press; 2013. p. 1–18. see also: https://www.elsevier.com/books/emery-and-rimoins-principles-and-practice-of-medical-genetics/rimoin/978-0-12-383834-6.
Ferrari S, et al. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics. 2011;12(4):238–49.
Zhang Q. Retinitis pigmentosa: progress and perspective. Asia Pac J Ophthalmol (Phila). 2016;5(4):265–71.
Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125(2):151–8.
Fishman GA. Retinitis pigmentosa. Visual loss. Arch Ophthalmol. 1978;96(7):1185–8.
Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.
Berson EL. Retinitis pigmentosa. The Friedenwald lecture. Invest Ophthalmol Vis Sci. 1993;34(5):1659–76.
Murakami T, et al. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. Am J Ophthalmol. 2008;145(4):687–94.
Andersen K, Sauer L, et al. Characterization of retinitis pigmentosa using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7:20.
Dysli C, et al. Fundus autofluorescence lifetime patterns in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2018;59(5):1769–78.
Lima LH, et al. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. Retina. 2009;29(7):1025–31.
Aizawa S, et al. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Exp Ophthalmol. 2010;38(6):597–604.
Andersen KM, et al. Characterization of retinitis pigmentosa using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7(3):20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dysli, C., Solberg, Y., Sauer, L. (2019). Hereditary Retinal Diseases: Stargardt, Choroideremia, Retinitis Pigmentosa. In: Zinkernagel, M., Dysli, C. (eds) Fluorescence Lifetime Imaging Ophthalmoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-22878-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-22878-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22877-4
Online ISBN: 978-3-030-22878-1
eBook Packages: MedicineMedicine (R0)